title: A case for drug treatment of obesity.
abstract: Several brain receptor systems can modulate food intake. Thus, in a new strategy against obesity, the patient takes submaximal doses of two drugs that act by differing mechanisms.
authors.affiliation: Pennington Biomedical Research Center, Louisiana State University, Baton Rouge.
authors.forename: G A
authors.initials: GA
authors.lastname: Bray
mesh_terms: D000318:Adrenergic beta-Agonists / Q000145:classification / Q000494:pharmacology / Q000627:therapeutic use; D001067:Appetite Depressants / Q000145:classification / Q000494:pharmacology / Q000600:supply & distribution / Q000627:therapeutic use; D001294:Attitude to Health; D004983:Ethanolamines / Q000145:classification / Q000494:pharmacology / Q000627:therapeutic use; D013006:Growth Hormone / Q000145:classification / Q000494:pharmacology / Q000627:therapeutic use; D006801:Humans; D007783:Lactones / Q000145:classification / Q000494:pharmacology / Q000627:therapeutic use; D008049:Lipase / Q000037:antagonists & inhibitors; D009765:Obesity / Q000188:drug therapy*; D000077403:Orlistat; D012008:Recurrence; D013739:Testosterone / Q000145:classification / Q000494:pharmacology / Q000627:therapeutic use; D017211:Treatment Failure
chemical_list: D000318:Adrenergic beta-Agonists; D001067:Appetite Depressants; D004983:Ethanolamines; D007783:Lactones; D013739:Testosterone; C039248:BRL 26830A; D013006:Growth Hormone; D000077403:Orlistat; D008049:Lipase